StockData

FMC vs Ingevity

FMC and NGVT side by side, both in chemicals and allied products. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How FMC and NGVT compare

Ingevity is the larger company, worth 2.5 times as much as FMC ($2.2B against $877M).

Ingevity grew revenue faster over the last twelve months (−3.7% versus −22.0% for FMC).

Ingevity keeps more of each dollar of sales as profit, with a net margin of 5.3% compared with −151% at FMC.

FMC pays a dividend yielding 5.7%; Ingevity does not pay one.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricFMCNGVT
Size and price
Market cap$877M$2.2B
Share price$5.64$63.24
Change, 1 year−59.7%26.8%
Change, 5 years−94.6%−19.8%
Beta (5Y)0.801.21
Employees5,5001,500
StockData Score
Total score66
Valuation score1 (better)0
Growth score02 (better)
Performance score03 (better)
Health score11
Dividend score4 (better)0
Valuation
P/E–37.2×
P/S0.3× (better)1.9×
P/B–34.5×
EV/EBITDA–23.4×
P/FCF2.4× (better)17.7×
FCF yield42.2% (better)5.6%
Fair value–$35.84
Margin of safety–−76.5%
Growth
Revenue growth (TTM)−22.0%−3.7% (better)
Revenue growth, 5Y average−5.7%−0.81% (better)
Profitability
Gross margin22.0%42.0% (better)
Operating margin−97.0%–
Net margin−151%5.3% (better)
FCF margin13.1% (better)10.8%
Return on equity−227%59.5% (better)
Return on invested capital−38.4%–
Financial health
Debt / equity–18.18
Net debt / EBITDA–7.68
Interest coverage−10.0×–
Current ratio1.66 (better)1.48
Altman Z-score−0.192.31 (better)
Piotroski F-score26 (better)
Dividends and buybacks
Dividend yield5.7%–
Years of dividend growth0–
Dividend growth, 5Y average0.22%–
Buyback yield−46.0%7.2% (better)
Shareholder yield−40.3%7.2% (better)
Ownership
Held by institutions82.3%102%
Held by insiders20.9%1.4%
Insider net buying, 12 months$202K (better)−$1.8M
Superinvestors holding1–
Short interest, % of float31.2%3.7%

Go deeper

For information only, not investment advice. Check the source filings before relying on any figure.